Cefpodoxime Proxetil

   
Google
 
Web NewDrugInformation.com

Cefpodoxime Proxetil


Drug - Cefpodoxime Proxetil
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefpodoxime Proxetil
Multiple ingredients are in alphabetical order.

Strength - EQ 200MG BASE
The potency of the active ingredient(s), Cefpodoxime Proxetil. May repeat for multiple part products.

Applicant - RANBAXY
The firm name holding legal responsibility for Cefpodoxime Proxetil. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 065083
The FDA assigned number to Cefpodoxime Proxetil. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Cefpodoxime Proxetil. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 20, 2003
The date Cefpodoxime Proxetil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cefpodoxime Proxetil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cefpodoxime Proxetil is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ranbaxy Laboratories Ltd
The full name of the firm holding legal responsibility for the new application of Cefpodoxime Proxetil.

Cefpodoxime Proxetil